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ABSTRACT
Nonsense-mediated mRNA decay (NMD) is a sur-
veillance pathway that recognizes and rapidly de-
grades mRNAs containing premature termination
codons (PTC). The strength of the NMD response
appears to reflect multiple determinants on a
target mRNA. We have previously reported that
mRNAs containing PTCs in close proximity to the
translation initiation codon (AUG-proximal PTCs)
can substantially evade NMD. Here, we explore the
mechanistic basis for this NMD resistance. We dem-
onstrate that translation termination at an
AUG-proximal PTC lacks the ribosome stalling that
is evident in an NMD-sensitive PTC. This difference
is associated with demonstrated interactions of the
cytoplasmic poly(A)-binding protein 1, PABPC1, with
the cap-binding complex subunit, eIF4G and the 40S
recruitment factor eIF3 as well as the ribosome
release factor, eRF3. These interactions, in combin-
ation, underlie critical 30–50 linkage of translation
initiation with efficient termination at the AUG-
proximal PTC and contribute to an NMD-resistant
PTC definition at an early phase of translation
elongation.
INTRODUCTION
Nonsense-mediated decay (NMD) targets mRNAs har-
boring premature translation–termination codons (PTCs)
for rapid decay. This surveillance pathway limits the syn-
thesis of potentially deleterious C-terminally truncated
proteins encoded by mutant mRNAs (1–4). As such,
NMD serves as an important modiﬁer of many genetic
disorders (5–7). The NMD pathway also functions as an
important determinant of wild-type gene expression with
 10% of the mammalian transcriptome impacted by com-
ponents of the NMD apparatus (8–10). A comprehensive
description of the determinants and mechanisms of NMD
is therefore central to the understanding of both normal
and mutant gene expression.
A substantial body of evidence supports a role for the
supramolecular exon junction complexes (EJC) in trigger-
ing NMD. The EJC is deposited 20- to 24-nt upstream of
each exon–exon junction during transcript splicing in the
nucleus (11). These complexes are subsequently displaced
from the mature mRNA in the cytoplasm by the
elongating ribosome (12) during the ﬁrst round of trans-
lation [‘pioneer round of translation’; (13,14)]. If a PTC is
located >50–54nt 50 to the last exon–exon junction, one or
more EJCs will remain beyond the reach of the elongating
ribosome and will be retained on the mRNA. The retained
EJC(s) can interact with the translation termination
complex via bridging interactions between the release
complex-associated proteins, UPF1 and SMG-1 (15) and
the EJC-associated factors, UPF2–UPF3 (11). This
bridging interaction has been proposed to trigger accele-
rated decay (i.e. NMD) of the PTC-containing mRNA.
While multiple reports support a role for the EJC
complex in NMD, an accumulating body of data indicates
that additional determinants may play a signiﬁcant role in
this surveillance pathway. Converging lines of evidence
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elegans and Saccharomyces cerevisiae reveal that NMD
can be triggered independently of transcript splicing and
EJC deposition (9,16). These studies further reveal that
30-untranslated region (UTR) length and the proximity of
the PTC to the cytoplasmic poly(A)-binding protein 1
(PABPC1) may constitute critical determinants of NMD.
Studies in yeast support these ﬁndings by demonstrating
that correct positioning of the termination codon relative
to PABPC1 are necessary for efﬁcient termination and
NMD resistance (17). Recent studies in mammalian
cell-culture support the conclusion that the strength of
the NMD response is inversely related to the distance
between the PTC and PABPC1 (18,19); shortening this
distance by tethering PABPC1 in close proximity to an
otherwise NMD-sensitive PTC suppresses NMD, even in
the presence of a downstream EJC (18–21). In further
support of this model, it has been demonstrated in vitro
that PABPC1 can competitively block the association of
UPF1 with eRF3 (19) with a corresponding blunting of
UPF1 actions and the NMD response (19). Thus the
impact of PABPC1 on NMD appears to reﬂect its ability
to interact with, and alter the impact of, supramolecular
interactions at the translation termination complex.
We have previously reported that mRNAs containing
PTCs in close proximity to the translation initiation AUG
codon (AUG-proximal PTCs) escape NMD. This was ini-
tially surprising as these mRNAs would be expected to
contain residual EJCs and in addition would situate the
PTC quite far, in a linear sense, from the poly(A) tail and
PABP (22). Detailed analyses of AUG-proximal PTC
mRNAs revealed that their observed NMD resistance did
not reﬂect downstream translation reinitiation or extension
of ribosome elongation 30 of the PTC and was instead a
direct effect of the termination event being located in close
proximity to the AUG (23,24). Based on these studies, and
on the observation by others that PABPC1 is able to bind
simultaneously to the cap-binding complex subunit eIF4G
and to the poly(A) tail, [‘closed-loop’ mRNP conﬁguration
(25)], we have proposed a model in which the short open
reading frame on an AUG-proximal nonsense-mutated
mRNA, situates PABPC1 and its associated cap-binding
complex, in close proximity to the PTC. This proximity
would allow PABPC1 to alter the structure and/or
function of the translation termination complex with a
consequent inhibitory effect on NMD (4,21).
In the present report, we further focus on the mechanism
of NMD resistance of AUG-proximal PTCs. These studies
support the model in which PABPC1 is brought into close
proximity with an AUG-proximal PTC via interactions
with the translation initiation complexes. This proximity
of PABP to the AUG-proximal PTC allows PABP to
interact with eRF3 with a consequent enhancement of
the release reaction and repression of the NMD response.
MATERIALS AND METHODS
Plasmid constructs
The wild-type b-globin gene (bN), as well as the human
b-globin variants b15 and b39 were cloned into the
pTRE2pur vector (BD Biosciences) as previously de-
scribed (24). The pDEST26-PABPC1delC construct was
obtained by deleting the DNA fragment encoding the
C-terminal portion of PABPC1 from pDEST26-PABPC1
plasmid (IOH13850-pDEST26; RZPD). To accomplish
this deletion, the coding sequence of PABPC1, excluding
the C-terminal domain (NM 002568, nucleotides 2140–2394,
corresponding to C-terminal 85 amino acids), was amp-
liﬁed by PCR from pDEST26-PABPC1 using a pair of pri-
mers, one with an AgeI linker (primers #1 and #2; Table 1).
After HindIII digestion, the PCR DNA product was
inserted into HindIII/AgeI sites of pDEST26-PABPC1.
The pUHD-eRF3 plasmid was a generous gift of Marla
J. Berry. eRF3 cDNA sequence was then subloned into
pcDNA3.1 (Invitrogen). To obtain pcDNA-eRF3delN,
the coding sequence of eRF3, excluding the N-terminal
domain (X17644, nucleotides 1–648, corresponding to
N-terminal 138 amino acids), was ampliﬁed by PCR
from pcDNAeRF3 using a pair of primers, one with an
EcoRI linker and another with an EcoRV linker (primers
#3 and #4; Table1) and inserted into EcoRI/EcorV sites
on pcDNA3.1/hygro+(Invitrogen). The plasmid encoding
PAIP2, pDEST26-PAIP2 (o834B1117-pDEST26; RZPD)
was purchased from BD Bioscience.
Cell culture, plasmid and siRNA transfection
HeLa cells, stably expressing the tet transactivator (HeLa/
tTA) (26), were grown in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum.
siRNA duplexes (Table 2) were designed as 19-mers with
30-dTdT overhangs and purchased from Thermo.
Transfections of cells with siRNAs were carried out using
Lipofectamine 2000 Transfection Reagent (Invitrogen),
following the manufacturer’s instructions, in 35-mm
plates using 200pmol of siRNA oligonucleotides and
4ml of transfection reagent. Twenty-four hours later, cells
were transfected with an additional 50pmol of siRNAs
along with 300ng of the test construct DNA and
1700ng of pEGFP vector (BD Biosciences) to control
for transfection efﬁciency. Where speciﬁed, 1700ng of
Table 1. DNA oligonucleotides used in the current work
Primer Sequence (50 ! 30)
#1 GTGGAAAATCCAAAGGATTTGG
#2 ACCGGTCAAAGGTTCCTGACCTTGTAC
#3 CCGGAATTCGCCATGGAACTTTCAGAACC
#4 AAAGATATCTTAGTCTTTCTCTGGAACCAG
#5 GTGGATCCTGAGAACTTCAGGCT
#6 CAGCACACAGACCAGCACGT
#7 CGCAACCTCCCCTTCTACG
#8 GGTGACGGTGAAGCCGAG
#9 CTGCTCATTGCAGGCCAGAT
#10 GAGCCTGGGCCATGAAGAG
#11 CACCCAGTCATTTTGGCCTC
#12 CGACAGTTCCCAACAGGGTC
#13 GGACAAGCATGGTTTTAGGCA
#14 TGCTGCTCCTGAGTAATTCCC
#15 ATGGCGCAGACGCAGGG
#16 CCGCACTAGGCTGGAACATC
#17 FAM-GCAATGAAAATAAATGTTTTTTATT
#18 FAM-CCCTTGAGGTTGTCCAGGT
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eRF3delN or 1000ng of pDEST26-PAIP2 [since in the
study of Khalegpour et al. (27), 5000ng of PAIP2 DNA
resulted in a decrease of  30% of the reporter translation
in HeLa cells] were co-transfected with 300ng of the test
b-globin construct DNA.
RNA isolation
Total RNA from transfected cells was prepared using the
Nucleospin RNA extraction II (Marcherey-Nagel) follow-
ing the manufacturer’s instructions.
Reverse transcription-coupled quantitative PCR
Synthesis of cDNA was carried out using 2mg of total
RNA and Superscript II Reverse Transcriptase
(Invitrogen), according to the manufacturer’s instructions.
Real-time PCR was performed in ABI Prism 7000
Sequence Detection System, using SybrGreen Master
Mix (Applied Biosystems). Primers speciﬁc for b-globin
(primers #5 and #6; Table 1) and for puromycin (primers
#7 and #8; Table 1) were designed using the ABI Primer
Express software. Quantiﬁcation was performed using
the relative standard curve method (Ct, Applied
Biosystems). The following cycling parameters were
used: 10min at 95 C and 40 cycles of 15s at 95 C and
1min at 60 C. Technical triplicates from three to four in-
dependent experiments were assessed in all cases.
Semiquantitative RT–PCR
A total of 1500ng of total mRNA were reverse-
transcribed (RT) with Superscript II Reverse
Transcriptase (Invitrogen) according to the manufactur-
er’s standard protocol and using 250ng of Random
Primers (Invitrogen) in a ﬁnal volume of 20ml. The PCR
reactions for eIF3h, eIF3f or eIF3e and histone de-
acetylase 1 (HDAC1) cDNAs were performed in parallel
at similar conditions: 3ml of the RT product was ampliﬁed
in a 50-ml reaction volume using 0.2mM dNTPs, 1.5mM
MgCl2, 15pmol of each primer (primers #9 and #10 for
eIF3h, primers #11 and #12 for eIF3f, primers #13 and
#14 for eIF3e and primers #15 and #16 for HDAC1;
Table 1), 0.75U of Amplitaq (Promega) and 1 PCR
buffer (Promega). Thermocycler conditions were 95 C
for 4min followed by 26 cycles of 95 C for 45s, 56 C
for 45s and 72 C for 45s followed by a ﬁnal extension
of 72 C for 10min. Ten-microliter aliquots from each RT–
PCR sample were analyzed by electrophoresis on 1.8%
agarose gels.
SDS–PAGE and western blotting
Protein lysates were resolved, according to standard
protocols, in 10% SDS–PAGE and transferred to PVDF
membranes (Bio-Rad). Membranes were probed using
mouse monoclonal anti-a-tubulin (Sigma) at 1:10000
dilution, goat polyclonal anti-hUPF1 (Bethyl Labs) at
1:500 dilution, rabbit polyclonal anti-PABPC1
N-terminal domain (Cell Signaling) at 1:500 dilution, rab-
bit polyclonal anti-eRF3 (Abcam) at 1:500 dilution, goat
polyclonal anti-PAIP2 (Santa Cruz) at 1:250 dilution or
anti-GFP (Abcam) at 1:5000 dilution. Detection was
carried out using secondary peroxidase-conjugated
anti-mouse IgG (Bio-Rad), anti-rabbit IgG (Bio-Rad) or
anti-goat IgG (Sigma) antibodies followed by
chemiluminescence.
Toeprinting assay
The #17 or #18 primers (Table 1) were synthesized and
end labeled with 50-FAM (Invitrogen). Twenty picomoles
of primer and 200ng of capped and polyadenylated
mRNA were combined in 50mM Tris–HCl, pH 7.5,
heated to 68 C for 2min and cooled to 37 C for 8min
and immediately added to the translation mixture, com-
prising 60% rabbit reticulocyte lysate (RRL) (Promega),
28mM AcK, 180mM MgCl2, 102mg/ml creatine phospho-
kinase (Sigma), 6mM creatine phosphate (Sigma), 24mM
KCl, 15mM Hepes, 27mM amino acid mixture (Promega)
and 0.6U/ml RNase inhibitor (Invitrogen). Where
appropriated, 500mg/ml cycloheximide (Sigma) was
added before the reaction. The reactions were incubated
at 30 C for 20min. For the primer extension stage, 4mlo f
the translation reaction were supplemented with 50mM
Tris–HCl, pH 7.5, 40mM KCl, 3.5mM MgCl2,5 m M
DTT, 0.8mM each dNTP, 500mg/ml cycloheximide,
1.5U/ml ribonuclease inhibitor and 5U/ml Superscript II
reverse transcriptase (Invitrogen) in a ﬁnal volume of 20ml
and placed at 37 C for 10min. Primer extension products
were extracted with phenol, and the ethanol-precipitated
pellets were resuspended in 3ml of Hi-Di Formamide
(Applied Biosystems) and brought to a total volume of
12ml aliquot with Hi-Di Formamide, which included
0.5ml ROX 500 or 2500 size standard (Applied
Biosystems). The products were separated by electrophor-
esis using standard GeneScan conditions and analyzed
using the GeneMapper Software—version 3.7 (Applied
Biosystems).
RESULTS
Translation termination at an AUG-proximal PTC
obviates ribosome stalling characteristic of
NMD-sensitive PTCs
Given the demonstrated linkage between NMD and de-
fects in translation termination (17,19,28), we hypothes-
ized that translation termination at an NMD-resistant
Table 2. Sequences of the siRNAs used in the current work
siRNA Sequence (50 ! 30)
PABPC11 UCACUGGCAUGUUGUUGGA
PAB3UTR UUGAUCAGGGACCAUGAAA
eRF3a1 GAGGAACAGUCAUUGUGUG
eRF3a2 UCCUCUCAAGAGGAACAGU
UPF1a AAGAUGCAGUUCCGCUCCAUU
UPF1b GCAGCCACAUUGUAAAUCAUU
eIF3h1 ACUGCCCAAGGAUCUCUCU
eIF3h2 GAUCGGCUUGAAAUUACCA
eIF3f1 GUGAAGGAGAAAUGGGUUU
eIF3f2 AUACGCGUACUACGACACU
eIF3e1 CCAGGGAUGGUAGGAUGCU
eIF3e2 UGCAGAAUUGGGAUGCAGC
Luc CGUACGCGGAAUACUUCGA
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more distal NMD-sensitive PTC. This possibility was
explored by an in vitro ‘toeprinting’ analysis. We
compared the residency of terminating ribosomes at the
termination codon of the wild-type b-globin mRNA (bN),
at a NMD resistant ‘AUG-proximal’ stop codon (b15),
and at a more distal NMD sensitive PTC (b39). Capped,
polyadenylated bN, b15 and b39 mRNAs were each
incubated in translationally active RRL followed by
primer extension using a ﬂuorescently labeled primer
(#17 primer; Figure 1A and Table 1) and analysis of
reverse transcription products by capillary electrophoresis
(29,30) (Figure 1B). Parallel controls included incubation
of the mRNAs in RRL containing cycloheximide (CHX)
and incubation in buffers in the absence of RRL. CHX at
the levels used, blocks peptidyl transferase and should
therefore ablate toeprinting signals corresponding to the
terminating ribosome and accentuate signals correspond-
ing to ribosomes blocked at the initiation AUG codon
(‘AUG toeprint’). mRNA incubated in the absence of
RRL was used to distinguish genuine ribosome-generated
toeprints (TP) from primer extension ‘short-stops’ due to
mRNA secondary structures.
The toeprinting analyses of bN, b15 and b39 mRNAs
under each of the three incubation conditions are
summarized in Figure 1B. The predominant peak at
626nt observed on each of the three mRNAs represents
the full-length transcripts. A second peak corresponding
to the initiation AUG toeprint (at 555nt, AUG TP) is seen
for all three mRNAs (bN, b15 and b39 mRNAs), and in
each case it is appropriately enhanced by CHX. A toeprint
at 440nt is speciﬁcally observed on the b39 mRNA
incubated in the RRL. This band, mapping to a position
16nt 30 to codon 39, is ablated in the presence of CHX and
is not generated in the –RRL incubation. The position of
this toeprint is consistent with the presence of a stalled
ribosome at the b39 termination codon (PTC TP;
Figure 1B). The parallel analysis of the bN and b15
mRNAs failed to reveal and extension product of 116 or
512nt that could be ascribed to ribosome stalling at the
normal stop codon or at codon 15, respectively.
To conﬁrm and extend the initial toeprinting study, a
reanalysis of the b15 and b39 transcripts was performed
with a primer positioned closer to the PTCs to achieve
higher resolution (#18 primer; Figure 1C and Table 1).
The b15 and b39 mRNAs both generate a peak at 230nt
(Figure 1D) that is accentuated in the presence of CHX
(AUG TP; Figure 1D). This product maps to a position
18nt 30 the AUG codon, as conﬁrmed by direct sequenc-
ing with the same primer (Figure 1D). Additional
CHX-independent peaks, observed for both transcripts
in the presence but not in the absence of RRL most
likely represent mRNA regions where mRNA binding pro-
teins or structures impede cDNA synthesis. The analysis
of the b39 mRNA generated an additional peak at 115nt
that was not seen in the presence of CHX; this signal cor-
responds to a toeprint at 16nt downstream the PTC at
codon 39 (PTC TP; Figure 1D). No corresponding band
was observed immediately 30 to codon 15 of the b15
mRNA. It is unlikely that the absence of a toeprint cor-
responding to the b15 PTC is due to inefﬁcient translation
A
B
Figure 1. Translation termination at the AUG-proximal b15 PTC
occurs in the absence of the ribosome stalling evident at the more
distal b39 PTC. (A) Diagram of the human b-globin mRNA showing
positions of initiation and termination codons [native (N) or premature
(at position 15 or 39)]. The arrow indicates the position and orientation
of the #17 primer (Table 1) used in the primer-extension (toeprinting)
assays. The lines below the mRNA diagram represent the length in
nucleotides of the synthesized cDNA from the #17 primer to the 50-
end of the mRNA, the initiation AUG codon, or to the bN, b15 and
b39 translation termination codons. (B) Electropherograms of bN, b15
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Figure 1. Continued
and b39 toeprint assays using the ﬂuorescently labeled #17 primer. The toeprint reactions were performed in the presence or absence of
cycloheximide (+CHX or  CHX, respectively). A control reaction was carried out in the absence of added rabbit reticulocyte lysate ( RRL).
Primer extension products were suspended in a mix containing ROX 2500 molecular weight marker (Applied Biosystems) and subjected to capillary
electrophoresis. Size standard peaks are shown below and sequence position is indicated in nucleotides. The toeprint peaks at 626nt represent the
full-length transcript; the peaks at 620nt correspond to the cap-binding complex-bound full-length transcript; the peaks at 555-nt map 18-nt
downstream the AUG codon (AUG TP). The peak at 440-nt maps to a position 16nt downstream the b39 stop codon (PTC TP). (C) The
arrow below the mRNA diagram represents position and orientation of #18 primer (Table 1) used in the second, high-resolution toeprinting
assays. The lines below the mRNA diagram represent the length in nucleotides of the primer-extended cDNA to the 50-end of the mRNA, to
the initiation AUG, as well as to the translation termination codons at positions 15 or 39. (D) Electropherograms of b15 and b39 toeprint assays
using the ﬂuorescently labeled #18 primer. A parallel sequencing reaction on the bN cDNA, performed with the same primer is shown on the top.
Underlined sequences indicate codon position: 0 (AUG), 15 and 39. The toeprint reactions were performed in the presence or absence of
cycloheximide (+CHX or  CHX, respectively). A control reaction lacking  RRL is shown. Primer extension and sequencing products were resus-
pended in a mix containing ROX 500 (Applied Biosystems) molecular weight standard and separated by capillary electrophoresis. Sequence position
is indicated in nucleotides. Peaks at 230nt correspond to the initiation AUG toeprint that maps 18-nt downstream the AUG codon. The peak at
115nt, present uniquely in the b39 analysis, maps 16-nt downstream of the PTC.
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toeprint that responds positively to CHX (Figure 1B
and D). Together, these in vitro studies reveal aberrant
ribosome termination/release at the b39 PTC that is not
seen at the b15 PTC.
PABPC1 plays an essential role in establishing NMD
resistance of an AUG-proximal nonsense-mutated mRNA
Prior studies have demonstrated that PABPC1 can asso-
ciate simultaneously with the cap-associated eIF4G and
the poly(A) tail (25). This dual binding has the potential
to bridge the 30 and 50 termini of an mRNA resulting in a
circularized or ‘closed loop’ conformation (25). Such a
conformation would bring PABPC1 into close proximity
with 50-terminal translation complexes. In related studies,
PABPC1 has been shown to inhibit NMD when located
close to the PTC (18–21) and this effect is dependent on its
C-terminal domain (21). With these observations in mind,
we hypothesized that PABPC1 might be brought into the
vicinity of the AUG-proximal PTC during cap-dependent
translation by binding to and tracking with the initiation
complex. This would allow it to interact with eRF3 and
repress NMD. To test this model, HeLa cells were trans-
fected with a siRNA targeting PABPC1. Twenty-four
hours later, these cells were transiently co-transfected
with a plasmid-encoding PABPC1 lacking the 85
residues of the C-terminal segment critical to eRF3 inter-
actions (31), (PABPdelC, see ‘Materials and Methods’
section) and with plasmid encoding bN, b15 or b39
mRNAs (Figure 2A). Levels of endogenous PABPC1
and exogenous PABPdelC proteins were monitored by
western blot (Figure 2B, lanes 4–6) and the impact of
altering the levels and structure of the PABPC1 on the
expression of the various b-globin mRNAs was monitored
by RT–quantitative PCR (RT–qPCR) (Figure 2C). The
studies were controlled by a parallel study in cells treated
with a control (Luciferase; LUC) siRNA (Figure 2B,
lanes 1–3). The data revealed that expression of the
C-terminally deleted PABPC1 in PABPC1-depleted cells
(Figure 2B, Lanes 4–6) results in a signiﬁcant decrease on
b15 mRNA (from 103% to 70% of bN). In contrast, the
same alteration in PABP constitution fails to alter b39
mRNA expression levels (Figure 2C). These observations
are consistent with the model that NMD evasion of b15
transcripts is dependent on PABPC1, and speciﬁcally on
a function mediated by its C-terminal domain. Efforts at
testing the single effect of endogenous PABPC1 depletion
on the NMD resistance of b15 transcripts failed because
HeLa cells became detached from plates after the second
transfection. The apparent toxicity of the siRNA-
mediated PABPC1 depletion suggests that the knockdown
of this critical factor was effective (our unpublished data).
The preceding experiment was repeated by directly
comparing the impact of the native PABPC1 versus the
PABPdelC mutant in the cells depleted of endogenous
PABPC1 (Figure 2D and E). HeLa cells were transfected
with a siRNA targeting the 30-UTR region of PABPC1-
encoding mRNA (PAB3UTR; Table 2). Twenty-
four hours later, the PABPC1-depleted HeLa cells were
co-transfected with plasmids encoding the b-globin
reporters and with a plasmid-encoding PABPdelC
protein (Figure 2D, lanes 4–6) or encoding exogenous
PABPC1 (with a 30-UTR resistant to PABPC1-directed
siRNA, Figure 2D, lanes 7–9). Levels of b-globin
mRNAs were measured by RT–qPCR (Figure 2E). As
before, we observed that depletion of PABPC1, followed
by expression of PABPdelC (Figure 2D, lanes 4–6 versus
lanes 1–3), decreased b15 mRNA levels while the corres-
ponding levels of the b39 mRNA remained unaltered
(Figure 2F). In contrast, repletion of the cells with
wild-type PABPC1 from  40–50% to  75–95% of the
normal protein levels (Figure 4D, lanes 7–9 versus lanes
4–6) fully restored b15 mRNA levels so that they were
comparable to bN mRNA levels, while b39 mRNA
remained at low levels (Figure 2E). Together, these
results demonstrate that the NMD resistance of the b15
RNA is dependent on the action of PABPC1 and in par-
ticular on the function of its C-terminal domain.
Interaction of PABPC1 with the ribosome release factor,
eRF3, is critical to NMD evasion by an AUG-proximal
nonsense-mutated mRNA
Prior studies have revealed that PABPC1 can bind to
eRF3 (15,31–36). This binding blocks UPF1 binding to
the release complex. PABPC1 is thus able to antagonize
the UPF1–eRF3 interaction involved in NMD (19).
PABPC1 interacts with the N-terminal domain of eRF3
(33,37), while UPF1 interacts with the non-overlapping
eRF3 GTPase domain (20). To further test the model
that NMD resistance of the AUG-proximal nonsense-
mutated transcripts relies on the PABPC1–eRF3 inter-
action, we depleted HeLa cells of eRF3 by siRNA treat-
ment and subsequently co-transfected these cells with
plasmids bearing the b-globin reporters genes (bN, b15
or b39) and with a plasmid encoding an eRF3 mutant
protein lacking its N-terminal domain [residues 1–183
(eRF3delN)]. Importantly, this deletion does not impair
eRF3–eRF1 or eRF3–UPF1 interactions (20,34). eRF3
levels as monitored by western blot were depleted to
 25% of wild-type levels (Figure 3A, lanes 4–6 versus
lanes 1–3). Under these eRF3-depleted conditions, the ex-
pression eRF3delN resulted in a signiﬁcant repression of
b15 mRNAs to 55% of bN mRNA levels, while levels of
b39 transcript were not appreciably altered (Figure 3B).
These results, along with those summarized in Figure 2,
lead us to conclude that an AUG-proximal nonsense-
mutated mRNA can evade NMD through a mechanism
that is dependent on the interaction of PABPC1 with
eRF3.
Inhibition of PABPC1 function by PAIP2 sensitizes an
AUG-proximal nonsense-mutated mRNA to NMD
The closed loop conﬁguration of a capped mRNA is de-
pendent on the PABPC1–eIF4G interaction. The
PABP-interacting protein 2, PAIP2, competitively blocks
this interaction via direct binding to PABPC1 (38). We
therefore reasoned that over-expression of PAIP2 might
sensitize an AUG-proximal nonsense-mutated mRNA to
NMD by inhibition of the closed loop conformation. To
ensure that the PAIP2 over-expression was not having a
Nucleic Acids Research,2012, Vol.40, No. 3 1165A
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Figure 2. PABPC1 plays an essential role in NMD resistance of an AUG-proximal PTC. (A) Diagram representing bN, the NMD-resistant b-globin
mRNA with an AUG-proximal nonsense mutation at codon 15 (UGA; b15) and the NMD-sensitive b39 mRNA. The positions of initiation (AUG)
and termination (native and premature) codons are indicated. (B) Representative western blot analysis of HeLa cells extracts transfected with human
PABPC1 siRNA (lanes 4–6) or with a control Luciferase siRNA target (LUC siRNA; lanes 1–3). Twenty-four hours after siRNA treatment, cells
were transfected with the b-globin reporter constructs (bN, b15 or b39) with or without a plasmid expressing PABPdelC mutant protein
(pDESTPABPC1delC plasmid); lanes 4–6 or 1–3, respectively. Twenty-four hours post-transfection, protein and RNA were isolated from the
cells for analysis. Immunoblotting to conﬁrm PABPC1 knockdown was carried out with anti-PABPC1 (speciﬁc for the N-terminal domain) and
with anti-a-tubulin antibodies as a loading control (lanes 4–6 versus lanes 1–3). Identiﬁcation of each band is on the right. (C) Depletion of
endogenous PABPC1 in conjunction with expression of exogenous PABPdelC protein represses b15 mRNA levels. Relative b-globin mRNA
levels under control conditions (LUC siRNA-treated HeLa cells; dark bars) and at conditions of PABPdelC expression in PABPC1-depleted
HeLa cells (PABPC1 siRNA+PABPdelC overexpression; light bars), normalized to the levels of puromycin resistance mRNA (Puro
r; plasmids
carrying the reporter b-globin gene also contain the Puro
r gene), were determined by quantitative RT–qPCR and compared to the corresponding bN
mRNA levels (deﬁned as 100%). Average and standard deviation (SD) of three independent experiments corresponding to three independent
transfections are shown in the histogram. (D) Representative western blot analysis of HeLa cells extracts transfected with control Luciferase
siRNA (LUC siRNA; lanes 1–3) or with siRNA targeting the human PABPC1 30-UTR (PABPC1 30-UTR siRNA; lanes 4–9). After siRNA
treatment, cells were transfected with the plasmids expressing bN, b15 or b39 mRNAs (lanes 1–3) or cotransfected with these plasmids in combin-
ation with a plasmid expressing PABPdelC mutant protein [pDESTPABPC1delC plasmid as above in (B); lanes 4–6], or with a plasmid expressing
wild-type PABPC1 (encoded by an mRNA with an heterologous 30-UTR resistant to the PABPC1 siRNA; lanes 7–9). Protein levels present in the
cell extracts were analyzed by western blot for PABPC1 and a-tubulin (loading control) as in (B), to monitor endogenous PABPC1 knockdown
(lanes 4–9 versus lanes 1–3) and exogenous expression of mutant PABPdelC protein (lanes 4–6) or PABPC1 expression rescue (lanes 7–9).
Identiﬁcation of each band is indicated to the right of the gel image. The histogram below the immunoblot shows the average and SD values of
three independent experiments for quantiﬁcation of relative PABPC1 protein levels. (E) Expression of wild-type PABPC, but not PABPdelC, restores
b15 expression in PABPC1 depleted cells. Relative b-globin mRNA levels for the control conditions (LUC siRNA-treated cells; dark bars), at
conditions of PABPdelC expression in PABPC1-depleted HeLa cells (PABPC1 siRNA+PABPdelC overexpression; light bars), and at conditions of
PABPC1 rescue (PABPC1 siRNA-treated cells plus expression of exogenous PABPC1; light bars) were determined by RT–qPCR and compared to
the corresponding bN mRNA levels as in (C). Average values and SD of three independent experiments corresponding to three independent
transfections are shown in the histogram. All values are represented as a percentage (%) of the corresponding bN mRNA (deﬁned as 100%).
1166 Nucleic Acids Research, 2012,Vol.40, No. 3secondary effect on NMD efﬁciency via a repression of
translation, we limited our studies to low concentrations
of PAIP2 DNA (see ‘Materials and Methods’ section).
HeLa cells were transiently co-transfected with the plas-
mids encoding bN, b15, or b39 mRNAs along with the
plasmid-encoding PAIP2. PAIP2 protein levels were moni-
tored by western blot (Figure 4A; lanes 1–3 versus lanes 4–9)
and levels of b-globin mRNAs were quantiﬁed by RT–
qPCR (Figure 4B). PAIP2 expression induced a substan-
tial decrease in b15 mRNA levels from 117% to 53% of
the corresponding bN mRNA levels, without altering the
expression of the b39 mRNA (Figure 4B). To conﬁrm that
the decrease of b15 mRNA levels seen in the PAIP2
treated cells reﬂected NMD, the experiment was repeated
in UPF1-depleted HeLa cells. The UPF1 depletion resulted
in the expected increase in b39 mRNA and, in addition,
reversed the repressive effect of the PAIP2 over-expression
on b15 mRNA (Figure 4A and B). These data lead us to
conclude that an AUG-proximal nonsense-mutated
mRNA can be sensitized to NMD by blocking the inter-
action of PABPC1 with eIF4G.
The eIF3 subunits that tether the 40S ribosomal subunit
to eIF4G are required for NMD resistance of an
AUG-proximal nonsense-mutated mRNA
Interactions between mRNA 50-end and the poly(A) tail
are thought to be established during the initial round of
translation. These interactions involve interactions of
PABPC1 with the initiation factor eIF4G. eIF4G can sim-
ultaneously interact with PABPC1 and with the 40S re-
cruitment factor, eIF3 (39). Mammalian eIF3 is composed
of 13 subunits designated eIF3a to eIF3m (40–42). The
structure and organization of this multisubunit has not
been complete elucidated, although crystallography, mass
spectrometry and immunoprecipitation studies allows the
prediction of an interaction map of the free eIF3 as it is
represented in Figure 5A [adapted from (40–42)]. The
eIF3–eIF4G interaction is established via eIF3e and
eIF3f subunits (40,43). This interaction of eIF4G with
eIF3 has the potential to retain the eIF4G-bound
PABPC1 on the scanning 40S ribosome and on the 80S
ribosome during the early phase of elongation. Besides, in
plants, the eIF3h subunit helps to prevent the permanent
loss of reinitiation competence (44), suggesting that this
subunit might also be involved in tethering 40S to eIF4G.
Such an activity could blunt NMD of an AUG-proximal
nonsense-mutated mRNA by bringing the PABPC1 into
close proximity with the PTC. To test this hypothesis, we
assessed the impact of depleting eIF3 subunits on the ex-
pression of an AUG-proximal PTC mRNA. Efﬁcient
knockdown was conﬁrmed at the mRNA level for each
respective eIF3 subunit mRNA, by normalization to
mRNA levels of the histone deacetylase 1 (HDAC1)
(Figure 5B–D). HDAC1 mRNA was chosen as an internal
control for these analyses since it is constitutively ex-
pressed (45). We further demonstrated that under the ex-
perimental conditions used in the study, these depletions
did not alter cellular translation as assessed by GFP
reporter expression (Figure 5E, lanes 3–5 versus lane 2
and 1).
We next evaluated the effect of individually depleting
each of the three eIF3 subunits on NMD. Genes encoding
AB
Figure 3. The N-terminal domain of eRF3 is critical to NMD evasion by an AUG-proximal nonsense-mutated mRNA. (A) Western blot analysis of
HeLa cells extracts transfected with human eRF3 siRNA (lanes 4–6) or with a control Luciferase siRNA target (LUC siRNA; lanes 1–3). After
siRNA treatment, cells were transfected with plasmids expressing bN, b15 or b39 mRNAs with or without a plasmid expressing eRF3delN mutant
protein (pcDNAeRF3delN plasmid); lanes 4–6 or 1–3, respectively. Twenty-four hours post-transfection, protein and RNA were isolated from the
cells. Immunoblotting was carried out with anti-eRF3 to monitor endogenous eRF3 knockdown (lanes 4–6 versus lanes 1–3) and expression of
mutant eRF3delN protein (lanes 4–6). Detection of a-tubulin served as a loading control. Identiﬁcation of each band is on the right. (B) Depletion of
endogenous eRF3 in combination with expression of exogenous eRF3delN represses b15 mRNA levels. Relative levels of b-globin mRNA under
control conditions (LUC siRNA-treated cells; dark bars) and in eRF3-depleted cells expressing exogenous eRF3delN protein (eRF3
siRNA+eRF3delN overexpression; light bars), normalized to the levels of Puro
r mRNA expressed from the b-globin plasmids, were determined
by quantitative RT–PCR and compared to the corresponding bN mRNA levels (deﬁned as 100%). Average and SD values of four independent
experiments corresponding to three independent transfections are shown in the histogram.
Nucleic Acids Research,2012, Vol.40, No. 3 1167the b15, b39 and bN mRNAs were each transiently ex-
pressed in eIF3h-, eIF3f- or eIF3e-depleted HeLa cells.
b-globin mRNA levels, quantiﬁed by RT–qPCR,
revealed that eIF3h depletion (Figure 5F, lanes 4–6
versus lanes 1–3) results in a decrease of b15 mRNA
level from 113% to 79% of the corresponding normal con-
trol without a corresponding effect on the b39 mRNA
(Figure 5G). A similar selective repression of b15
mRNA was observed in eIF3f-depleted cells (Figure 5H
and I). In contrast, depletion of eIF3e (Figure 5J) had no
appreciable effect on b15 NMD-resistant transcript levels
(Figure 5K). Instead, this depletion results in an increase in
b39 mRNA levels [from 37% to 59% of bN; (Figure 5K)].
This later result is consistent with prior observations that
the eIF3e subunit may be required, at least in part, for
NMD-commitment (46). The destabilizing effect of eIF3h
and eIF3f depletions on the b15 mRNA, together with the
suggestion that eIF3 remains bound to the translating
ribosome for a few peptide bonds (47,48) are consistent
with the model where eIF3h and eIF3f have a role in
bringing PABPC1 in association with eIF4G into the
vicinity of the PTC of an mRNA with a short open
reading frame. A schematic of this model is shown in
Figure 6.
DISCUSSION
We have previously reported that mammalian mRNAs
bearing AUG-proximal PTCs evade NMD (22,24). This
immunity to NMD is independent of sequence context of
the open reading frame and PTC, independent of tran-
script identity, and appears to be a general attribute of
the mammalian NMD pathway (24). Extensive mapping
studies, using the human b-globin gene as a primary
model, have revealed that this effect reﬂects a close prox-
imity of a PTC to the translation initiation codon (23,24).
In the case of the b-globin mRNA, PTCs that occur up to
23 codons into the open reading frame effectively evade
NMD while mRNAs with PTCs at a greater distance from
the AUG are targeted for decay. We have further demon-
strated that NMD evasion by AUG-proximal PTCs does
not, as a rule, reﬂect defects in transcript splicing,
impaired translation or reinitiation of translation 30 to
the PTC (23,24). Thus, the mechanism underlying the
NMD resistance of the AUG-proximal nonsense-mutated
mRNA remains to be more clearly delineated.
The potential role of translation reinitiation in NMD
resistance of AUG-proximal PTCs has been the subject
of a recent report. In that study (49) the NMD resistance
of b-globin AUG-proximal nonsense-mutated mRNAs
was attributed to translation reinitiation 30 to the PTC.
It may be of importance, however, to note that the inter-
pretation of these studies is complicated by the use of a
b-globin gene in which exon 1 was transformed into a
functional exon 2 by the introduction of an exogenous
intron into the 50-UTR. The expression of this recombin-
ant b-globin gene, even lacking a PTC, was repressed
when compared to the normal b-globin transcript.
In contrast, we have found using globin genes with
native structures, that even in cases in which we do
detect some level of reinitiation 30 to the AUG-proximal
PTC, site-speciﬁc elimination of the reinitiation sites
fails to fully restore NMD sensitivity (24). Thus, while a
contribution of translation reinitiation in NMD eva-
sion cannot be completely ruled out in any particular cir-
cumstance, our detailed analyses of the human b-globin
B A
Figure 4. Overexpression of PAIP2 induces NMD sensitivity in the b15 nonsense-mutated mRNA. (A) Western blot analysis of HeLa cells treated
with siRNAs speciﬁc to Luciferase (LUC) (lanes 1–6), or siRNA targeting UPF1 (lanes 7–9). After siRNA treatment, cells were transfected with
plasmids expressing bN, b15 or b39 mRNAs with or without a plasmid expressing PAIP2 protein (pDEST26PAIP2 plasmid); lanes 4–9 or 1–3,
respectively. Twenty-four hours post-transfection, protein and RNA were isolated from the cells for analysis. Immunoblotting was carried out with
anti-UPF1, anti-PAIP2 and anti-a-tubulin antibodies. Detection of a-tubulin served as a loading control. Identiﬁcation of each band is indicated to
the right of the gel image. (B) Overexpression of PAIP2 represses b15 mRNA levels in a UPF1-sensitive manner. Relative b-globin mRNA levels
under control conditions (dark bars), PAIP2 overexpression (dark grey bars), and in conditions of PAIP2 overexpression co-existing with UPF1
depletion (light bars) are shown. All values determined by RT–qPCR are normalized to the mRNA levels of Puro
r, and compared to the corres-
ponding bN mRNA levels. Average values and SD of four independent experiments corresponding to four independent transfections are shown. All
values are represented as a percentage (%) of the corresponding bN mRNA (deﬁned as 100%).
1168 Nucleic Acids Research, 2012,Vol.40, No. 3gene lead us to conclude that AUG proximity is a major
inhibitor of the NMD pathway, but other mechanisms can
be considered.
The present data points to a major role for PABPC1 in
protecting mRNAs harboring AUG-proximal PTCs from
the NMD surveillance pathway (4,21). A critical contribu-
tion of interactions between PABPC1 and components of
translation initiation complexes is highlighted by the
dependence of the NMD evasion on interactions of
PABPC1 with the eIF4G and most probably of eIF4G
with eIF3 subunits. The data further reveal that these
interactions are linked to the establishment of an efﬁcient
translation termination reaction at the AUG-proximal
PTC. Toeprinting analysis of capped and polyadenylated
human b-globin transcripts reveals substantial ribosome
stalling at the NMD sensitive b39 stop codon that is
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Figure 5. The translation initiation factors eIF3h and eIF3f are required for the NMD-resistant phenotype of the b15 nonsense-mutated mRNA. (A)
Representation of the predicted organization of the mammalian eIF3 subunits [adapted from (40–42)]. Free eIF3 complex can be assigned into three
stable modules. One module consists of eIF3a, b, g and i, and it interacts with a second module composed by eIF3c, d, e, l and k. eIF3b functions as
a scaffold protein connecting eIF3a, c, i and g subunits. The third subcomplex is composed by eIF3f, h and m. Subunits eIF3f and m bind to the
subcomplex eIF3 c:d:e:l:k through subunit eIF3h. The remaining subunit eIF3j, a labile subunit, attaches to the complex via eIF3b (40–42). (B–D)
Representative RT–PCR analyses of RNAs extracted from untreated (Ctl; lane 1), Luciferase (LUC; lane 2) or eIF3h, eIF3f and eIF3e (lane 3)
siRNAs-treated HeLa cells, respectively, in panels (B–D). RT–PCRs were carried out with eIF3h, eIF3f or eIF3e mRNA speciﬁc primers to monitor
endogenous eIF3h, eIF3f or eIF3e knockdown, respectively (lanes 3 versus lanes 1–2). The eIF3h, eIF3f and eIF3e mRNA levels were normalized to
those of histone deacetylase 1 (HDAC1) mRNA level. In each panel, the right three lanes correspond to serial dilutions of RNA, demonstrating
semiquantitative conditions used for RT–PCR. (E) Representative western blot analysis of HeLa cells extracts, untreated (Ctl, lane 1) or treated with
Luciferase (LUC; lane 2), eIF3h (lane 3), eIF3f (lane 4) or eIF3e (lane 5) speciﬁc siRNAs (see ‘Material and Methods’ section). After siRNA
treatment, cells were transiently transfected with the pEGFP plasmid (BD Biosciences) expressing green ﬂuorescent protein (GFP). Protein lysates
were analyzed by immunoblotting using anti-GFP and anti-a-tubulin (loading control) antibodies to monitor GFP protein expression. Identiﬁcation
of each band is indicated to the right of the gel image. (F, H and J) Semiquantitative RT–PCR analyses of RNAs extracted from HeLa cells
transfected with a Luciferase (LUC) siRNA target (lanes 1–3) or human eIF3h, eIF3f or eIF3e siRNAs, respectively, at panels (F, H or J) (lanes 4–6
of each panel), using the same experimental settings as in (B). Twenty-four hours after siRNA-treatment, cells were transfected with plasmids
expressing bN, b15 or b39 mRNAs. Twenty-four hours after constructs transfection, total RNA was isolated from the cells. RT–PCR was carried
out as in (B) with eIF3h, eIF3f or eIF3e mRNA speciﬁc primers, respectively, to monitor endogenous eIF3h, eIF3f or eIF3e knockdown (lanes 4–6
versus lanes 1–3). (G) Knockdown of eIF3h represses b15 mRNA levels. Relative b-globin mRNA levels for the control conditions (LUC siRNA;
dark bars) and at conditions of eIF3h depletion (eIF3h siRNA; light bars), normalized to the levels of puromycin resistance mRNA encoded from
the b-globin gene plasmid, were determined by quantitative RT–PCR (RT–qPCR) and compared to the corresponding bN mRNA levels (deﬁned as
100%). (I) Knockdown of eIF3f represses b15 mRNA levels. Relative b-globin mRNA levels for the control conditions (LUC siRNA; dark bars) and
at conditions of eIF3f depletion (eIF3f siRNA; light bars), normalized to the levels of puromycin resistance mRNA were determined by RT–qPCR
and compared to the corresponding bN mRNA levels (deﬁned as 100%). (K) Knockdown of eIF3e fails to repress b15 mRNA expression. Relative
b-globin mRNA levels for the control conditions (LUC siRNA; dark bars) and at conditions of eIF3e depletion (eIF3e siRNA; light bars),
normalized to the levels of puromycin resistance mRNA were determined by RT–qPCR as in (G) and compared to the corresponding bN
mRNA levels (deﬁned as 100%). (G, I and K) histograms show average and SD values of three independent experiments corresponding to three
independent transfections.
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(continued)absent at the termination codon of the b15 mRNA, as well
as at the stop codon of the normal transcript (Figure 1).
The results of these studies lead us to conclude that the
interactions of PABPC1 with the pre-initiation complex
and 40S ribosome place it in a favorable context to
enhance translation termination efﬁciency.
How does the positioning of the PABPC1 at the 50-end
of the mRNA speciﬁcally blunt the NMD response on an
AUG-proximal nonsense-mutated mRNA? Our current
observations lead us to propose that this repositioned
PABPC1 can enhance the efﬁciency of the translation ter-
mination at the AUG-proximal PTC and in so doing
represses NMD. It has been demonstrated by others that
PABPC1 can compete with UPF1 for binding to eRF3
with a consequent antagonistic effect on NMD response
(19,20). Recruitment of PABPC1 to the 50-end of the
mRNA, with retention of ribosome association during
the early phase of elongation, would position PABPC1
in close proximity to an early PTC. An impact on the
termination reaction is supported by our prior demonstra-
tion that AUG-proximal nonsense-mutated transcripts
fail to bind UPF1 as efﬁciently as NMD-sensitive tran-
scripts (21). The interactions that support the reposition-
ing of PABPC1 close to an AUG-proximal PTC are
further deﬁned by the in vitro observation that interactions
of PABPC1 with eIF4G, eIF4E and eIF3, and the termin-
ation factors eRF1 and eRF3 can form a closed loop
structure during translation of short mRNAs (39). The
proposed role for PABPC1 in blunting NMD on
AUG-proximal nonsense-mutated mRNAs is also consist-
ent with the observation by ourselves and others of an
inverse relationship between the distance among the
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Figure 5. Continued.
1170 Nucleic Acids Research, 2012,Vol.40, No. 3PTC and an artiﬁcially tethered PABPC1 and the strength
of NMD [for review, see (2,4)]. It is worth noting that the
destabilization of transcripts bearing AUG-proximal
PTCs obtained by the impairment of PABPC1–eRF3
interaction corroborates the importance of the AUG-
proximity effect in NMD-evasion of such transcripts.
In the case of the AUG-proximal nonsense-mutated
mRNA, our data support the conclusion that the
PABPC1–eIF4G interaction enables PABPC1 to travel
with the eIF4F/43S complex, as it scans from the cap to
the AUG. The dependence of the AUG-proximity effect
on the function of eIF3 (Figure 5), which bridges 43S
complex to eIF4G (48), further supports this model.
Thus, we provide evidence that eIF4G and eIF3 initiation
factors are both implicated in PABPC1 inhibitory effect
on NMD. This model is further supported by the obser-
vation that the interruption of the PABPC1–eIF4G inter-
action by over-expression of PAIP2 leads to NMD of
transcripts bearing an AUG-proximal PTC (Figure 4).
The observations that eIF3 can remain bound to the
translating ribosome during the initial phase of elongation
(47,48) and that it can function as the link between the
eIF4F-bound mRNA (through eIF4G) and the 40S ribo-
somal subunit (43), supports the notion that eIF3 subunits
might be involved in the delivery of eIF4G-associated
PABPC1 to the vicinity of the AUG-proximal PTC. The
strength of the NMD effect decay would then be
determined by the physical distance between PABPC1 at
the AUG vicinity and the PTC; the closer this distance, the
more effectively PABPC1 could interact with eRF3, di-
minishing the binding of UPF1, with the consequent
enhancement of translation termination and blunting of
the NMD response (Figure 6).
Considering that mRNA circularization (25,50) and
PABPC1 function as NMD inhibitor when located in
the PTC proximity (17–21) are common features in all
eukaryotes, the model for the AUG-proximity effect that
we propose here might be also a general attribute for these
organisms. Here, we show that the human eIF3h and
eIF3f subunits, which are not conserved in S. cerevisiae,
have a role in bringing PABPC1 in association with eIF4G
into the vicinity of an AUG-proximal PTC. While the in-
dividual functions of the different mammalian subunits
are not yet well established, many of the eIF3 subunits
are thought to be conserved (40–42,48). Indeed, the ﬁve
subunits that constitute the yeast eIF3—eIF3a, b, c, g and
i—are conserved in mammalian (48,51,52). However,
mammalian eIF3 has evolved to include additional sub-
units, which are likely to function as speciﬁc regulatory
factors and some extra structural motifs provide the
capacity to mediate extra protein-protein or protein–
RNA interactions. Accordingly, eIF3e possesses a PCI
(proteosome-COP9-initiation factor) domain, and eIF3f
and eIF3h have a MPN (Mpr1-Pad1-N-terminal)
domain. PCI or MPN domains are found in components
of large protein complexes and have been implicated in
protein–protein interactions (52). In fact, several results
have indicated that the non-core subunits of the mamma-
lian eIF3 regulate speciﬁc mRNAs (53–55). Also, one
attractive hypothesis is that the presence of a particular
non-core subunit, e.g. eIF3h in the eIF3 protein complex,
may in turn, govern the efﬁciency with which the 43S
pre-initiation complex is able to scan through the
50-UTR of a particular set of mRNAs (56). In addition,
the non-core subunits may serve to stabilize the eIF3
complex (40) and/or may have redundant functions (55).
It has been shown that mammalian subunits eIF3f:h:m
constitute a stable module that is located on the periphery
of the complex and is not involved in interactions between
other subunits (41). Also, it is known that subunit eIF3h is
essential for binding the trimer f:h:m to the core eIF3c
subunit (41). Based on these data, the possibility exists
that in yeast, the model for the AUG-proximity effect
may be dependent on the eIF3c, which may not evolved
in order to become as specialized as its mammalian
ortholog and thus it performs different biological func-
tions, among which, those attributable to the mammalian
eIF3f and h subunits. The relevance of the mammalian
non-conserved eIF3f and h subunits in bridging eIF4G
in association with PABPC1 to the ribosome during the
process of translation initiation, which seem to be main-
tained during the ﬁrst steps of elongation, might be linked
to the need of a tighter regulation of translation in higher
eukaryotes.
In conclusion, the present data support a role for
PABPC1 and associated translation initiation factors in
NMD evasion of AUG-proximal nonsense-mutated tran-
scripts. Future efforts addressing the biochemical mechan-
ism by which PABPC1 is involved in cap-dependent
translation initiation and how it participates in the
eIF4F/43S scanning will contribute to our understanding
of mRNA translation.
Figure 6. A model for NMD resistance of AUG-proximal
nonsense-mutated mRNAs. The current and prior data supports the
model shown in this ﬁgure. During cap-mediated translation initiation,
PABPC1 interacts with the initiation factor eIF4G. This interaction
indirectly tethers PABPC1 to the 40S ribosomal subunit via the inter-
action of eIF4G with eIF3 subunits. The resulting conﬁguration brings
PABPC1 into in the vicinity of the AUG initiation codon as a conse-
quence of 43S scanning and the maintenance of eIF4G–PABPC1 asso-
ciation with the 40S during the initial phase of translation elongation
brings it into close contact with an AUG-proximal PTC in a transcript
where the ORF is quite short. This proximity to the PTC allows
PABPC1 to interact with the release factor eRF3 at the termination
complex, thus impairing the association of UPF1 to the ribonucleo-
protein complex, resulting in efﬁcient translation termination and
inhibition of NMD.
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